Dissecting Tumor Response to Radiation Therapy Using Genetically Engineered Mouse Models
<p>Approximately 50% of all patients with cancer receive radiation therapy at some point during the course of their illness. Despite advances in radiation delivery and treatment planning, normal tissue toxicity often limits the ability of radiation to eradicate tumors. The tumor microenvironme...
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
2015
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10161/9790 |